Management holds a Key Opinion Leader Webinar with Robert Anderson, MD, PhD entitled, "The SNAPvax Platform for Inducing Tolerance to Treat Celiac and other Autoimmune Diseases" on November 28 at 4:30 pm. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VACC:
- Vaccitech to hold a KOL webinar
- Vaccitech to Host KOL Webinar on the SNAPvax™ Platform for Inducing Tolerance to Treat Celiac and other Autoimmune Diseases
- Vaccitech Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
- Vaccitech reports Q3 EPS 22c, consensus (33c)
- Vaccitech cancer vaccine ‘shows promise’ in animal studies, NIH researchers say
